Market Tracker

04/25 5:16pm ET

Heska Corp (NASDAQ:HSKA)

107.58
Delayed Data
As of Apr 25
 +0.18 / +0.17%
Today’s Change
26.26
Today|||52-Week Range
109.17
+50.25%
Year-to-Date
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up
Apr 20 / Zacks.com - Paid Partner Content
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
Apr 18 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne
Apr 20 / Zacks.com - Paid Partner Content
Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug
Apr 18 / Zacks.com - Paid Partner Content
Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III
Apr 19 / Zacks.com - Paid Partner Content
Roche's Hemophilia A Drug Positive in Second Phase III Study
Apr 17 / Zacks.com - Paid Partner Content
Arena Pharma (ARNA) Down After Underwritten Public Offering
Apr 19 / Zacks.com - Paid Partner Content
Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S.
Apr 17 / Zacks.com - Paid Partner Content
Create an Efficient Portfolio with 5 Top Stocks
Apr 19 / Zacks.com - Paid Partner Content
Biogen to License Alzheimer Candidate from Bristol-Myers
Apr 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.40
Today’s open107.79
Day’s range106.50 - 109.17
Volume56,949
Average volume (3 months)88,781
Market cap$760.0M
Dividend yield0.38%
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+93.24%
Earnings growth (this year)+18.88%
Earnings growth (next 5 years)+21.40%
Revenue growth (last year)+24.37%
P/E ratio75.2
Price/Sales4.05
Price/Book8.68

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.50+3.13%
INSYINSYS Therapeutics I...+0.15+1.45%
ACRSAclaris Therapeutics...-0.78-2.60%
MGNXMacroGenics Inc+0.55+2.63%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$130.1M
Annual profit (last year)$10.5M
Net profit margin8.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin S. Wilson
Secretary, Chief Operating &
Strategist Officer
Jason A. Napolitano
Corporate headquarters
Loveland, Colorado

Forecasts